Aqr Capital Management LLC Lexicon Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

  • $95.2 Billion
  • Q1 2025

A detailed history of Aqr Capital Management LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 1,173,225 shares of LXRX stock, worth $821,257. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,173,225
Holding current value
$821,257
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$0.29 - $0.96 $340,235 - $1.13 Million
1,173,225 New
1,173,225 $539,000
Q3 2023

Nov 14, 2023
BUY
$1.06 - $2.33 $1,591 - $3,497
1,501 Added 5.35%
29,558 $32,000
Q2 2023

Aug 14, 2023
BUY
$2.15 - $3.49 $60,322 - $97,918
28,057 New
28,057 $64,000
Q4 2022

Feb 14, 2023
SELL
$1.8 - $2.56 $455,769 - $648,204
-253,205 Reduced 84.34%
47,014 $89,000
Q3 2022

Nov 14, 2022
BUY
$1.94 - $3.43 $582,424 - $1.03 Million
300,219 New
300,219 $721,000
Q2 2022

Aug 15, 2022
SELL
$1.31 - $2.69 $62,456 - $128,251
-47,677 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.95 - $3.89 $139,614 - $278,512
-71,597 Reduced 60.03%
47,677 $100,000
Q4 2021

Feb 14, 2022
SELL
$3.81 - $6.16 $320,363 - $517,963
-84,085 Reduced 41.35%
119,274 $470,000
Q3 2021

Nov 15, 2021
SELL
$3.38 - $5.35 $411,160 - $650,800
-121,645 Reduced 37.43%
203,359 $978,000
Q2 2021

Aug 16, 2021
BUY
$4.12 - $5.87 $353,566 - $503,745
85,817 Added 35.88%
325,004 $1.49 Million
Q1 2021

May 17, 2021
BUY
$3.45 - $9.09 $406,354 - $1.07 Million
117,784 Added 97.02%
239,187 $1.4 Million
Q4 2020

Feb 16, 2021
SELL
$1.05 - $3.67 $547,837 - $1.91 Million
-521,750 Reduced 81.12%
121,403 $415,000
Q3 2020

Nov 16, 2020
SELL
$1.44 - $2.1 $809,107 - $1.18 Million
-561,880 Reduced 46.63%
643,153 $926,000
Q2 2020

Aug 17, 2020
SELL
$1.75 - $2.3 $417,205 - $548,326
-238,403 Reduced 16.52%
1,205,033 $2.4 Million
Q1 2020

May 15, 2020
BUY
$1.8 - $4.28 $1.54 Million - $3.66 Million
854,990 Added 145.3%
1,443,436 $2.82 Million
Q4 2019

Feb 14, 2020
BUY
$3.16 - $5.15 $1.72 Million - $2.8 Million
544,636 Added 1243.18%
588,446 $2.44 Million
Q3 2019

Nov 14, 2019
BUY
$1.2 - $6.66 $52,572 - $291,774
43,810 New
43,810 $132,000
Q4 2017

Feb 14, 2018
SELL
$8.77 - $12.28 $116,184 - $162,685
-13,248 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$12.17 - $16.3 $161,228 - $215,942
13,248
13,248 $163,000

Others Institutions Holding LXRX

# of Institutions
134
Shares Held
196M
Call Options Held
310K
Put Options Held
77.3K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $132M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email